Crossref
Rilzabrutinib: An Anti-inflammatory Therapy for Vaso-Occlusive Pain in Sickle Cell Disease
The Hematologist · 01.05.2026 · 23 (3)
DOI: 10.1182/hem.v23.3.202637 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Hematologist, online erschienen am 17.04.2026. Verfasst von Joshua G. Rivenbark und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rivenbark, J. G., & Wilson, S. R. (2026). Rilzabrutinib: An Anti-inflammatory Therapy for Vaso-Occlusive Pain in Sickle Cell Disease. The Hematologist, 23(3). https://doi.org/10.1182/hem.v23.3.202637
Vancouver
Rivenbark JG, Wilson SR. Rilzabrutinib: An Anti-inflammatory Therapy for Vaso-Occlusive Pain in Sickle Cell Disease. The Hematologist. 2026;23(3). doi:10.1182/hem.v23.3.202637
BibTeX
@article{Rivenbark2026,
author = {Rivenbark, Joshua G. and Wilson, Samuel R.},
title = {Rilzabrutinib: An Anti-inflammatory Therapy for Vaso-Occlusive Pain in Sickle Cell Disease},
journal = {The Hematologist},
year = {2026},
volume = {23},
number = {3},
doi = {10.1182/hem.v23.3.202637}
}
EUVIMED